United States Abdominal Stent Graft System Market Insight
Published: 27 May 2026 | Report Format: Electronic (PDF)
The United States Abdominal Stent Graft System Market is expected to grow at a CAGR of around 7.94% due to rising cases, increasing adoption of minimally invasive procedures, technological advancements, and supportive reimbursement policies
United States Abdominal Stent Graft System Market Forecasts to 2035
- The United States Abdominal Stent Graft System Market Size Was Estimated at USD 3,250.0 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.94% from 2025 to 2035
- The United States Abdominal Stent Graft System Market Size is Expected to Reach around USD 6,980.0 Million by 2035
Notable the United States Abdominal Stent Graft System Market
- Based on the product type, it can be observed that the Endovascular Aortic Repair (EVAR) Stent Graft segment is leading the United States Abdominal Stent Graft System Market in 2025, holding nearly 62% of the total market share due to rising preference for minimally invasive procedures and reduced post-operative complications in abdominal aortic aneurysm treatment.
- Based on the Segmentation by End-User, it can be seen that the Hospitals & Specialty Cardiac Centers segment held a market share of about 68% in 2025, mainly driven by advanced surgical infrastructure, high patient inflow for vascular procedures, and increasing adoption of advanced endovascular technologies.
- The United States Abdominal Stent Graft System Market has a revenue base of about USD 3.8 billion in 2025, supported by rising EVAR procedures, cases, and minimally invasive technologies, with leading companies generating nearly USD 2.6 billion collectively.
Download the eBook (ToC)
- Rising investments in advanced stent graft materials, image-guided systems, and endovascular innovations are boosting market growth, improving procedural success rates reducing recovery time by nearly 35% across hospitals.
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research, which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Abdominal Stent Graft System Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies United States Abdominal Stent Graft System Market
- Medtronic
- W. L. Gore & Associates
- Cook Medical
- Terumo Corporation
- Boston Scientific
- Endologix LLC
- Abbott Laboratories
- Lombard Medical
- MicroPort Scientific Corporation
- Braun Melsungen
- Others
Recent Developments:
- In September 2025, leading medical device companies in the U.S. expanded next-generation EVAR stent graft systems, improving procedural precision, reducing Endo leak risks, and enhancing long-term durability for abdominal aortic aneurysm (AAA) treatments across hospitals and vascular canters.
- In April 2025, major cardiovascular device manufacturers strengthened R&D in advanced endovascular graft materials and image-guided deployment systems, enabling improved implantation accuracy, reduced surgery time, and better patient recovery outcomes across the United States healthcare system.
Market Segmentation:
United States Abdominal Stent Graft System Market, By Product Type
- Endovascular Aortic Repair (EVAR) Stent Grafts
- Fenestrated Stent Grafts
- Branched Stent Grafts
- Custom-Made/Patient-Specific Stent Grafts
- Open Surgical Graft Alternatives
United States Abdominal Stent Graft System Market, By Technology
- Conventional Endovascular Repair Systems
- Advanced EVAR Delivery Systems
- Image-Guided Navigation & Deployment Technologies
- Next-Generation Biocompatible Graft Materials
- Hybrid & Minimally Invasive Repair Techniques
United States Abdominal Stent Graft System Market, By Application
- Hospitals
- Specialty Cardiac & Vascular Centers
- Ambulatory Surgical Centers (ASCs)
- Academic & Research Institutes
- Emergency & Trauma Care Facilities
Expert Views:
The United States Abdominal Stent Graft System Market is poised for steady expansion, driven by rising AAA prevalence, increasing EVAR adoption, and advanced device innovation. Strong hospital infrastructure, supportive reimbursement policies, and R&D in minimally invasive technologies are enhancing outcomes. Competitive intensity among key players is accelerating innovation, improving procedural efficiency and long-term patient recovery across vascular care systems.
Author: Govind and Krishna By Spherical Insights and Consulting